MyAverix Finance
US · Healthcare
Jupiter Neurosciences, Inc. Common Stock (JUNS)
Biotechnology
Jupiter Neurosciences, Inc. Common Stock (JUNS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for JUNS
Jupiter Neurosciences, Inc. Common Stock (JUNS) — FAQ
What is JUNS's P/E ratio?
The price-to-earnings (P/E) ratio for Jupiter Neurosciences, Inc. Common Stock (JUNS) is 25.00 (data as of 2026-05-23).
Does Jupiter Neurosciences, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Jupiter Neurosciences, Inc. Common Stock (JUNS). Check the MyAverix Finance app for the latest dividend data.
What sector is Jupiter Neurosciences, Inc. Common Stock in?
Jupiter Neurosciences, Inc. Common Stock (JUNS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is JUNS listed on?
JUNS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.